MNKD logo

MannKind (MNKD) Company Overview

Profile

Full Name:

MannKind Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 28, 2004

Indexes:

Not included

Description:

MannKind Corporation (MNKD) is a biopharmaceutical company focused on developing and commercializing innovative therapies for diabetes and other serious diseases. Their main product, Afrezza, is an inhalable insulin used to manage blood sugar levels in diabetes patients, offering a convenient alternative to traditional insulin injections.

Key Details

Price

$5.80

Annual Revenue

$198.96 M(+99.42% YoY)

Annual EPS

-$0.04(+88.24% YoY)

Beta

0.79

Events Calendar

Earnings

Next earnings date:

Feb 26, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 3, 2017

Analyst ratings

Recent major analysts updates

Dec 20, 24 Wells Fargo
Overweight
Dec 19, 24 RBC Capital
Outperform
Aug 28, 24 Oppenheimer
Outperform
Jun 13, 24 Rodman & Renshaw
Buy
May 9, 24 Cantor Fitzgerald
Overweight
Mar 15, 24 Cantor Fitzgerald
Overweight
Feb 28, 24 Cantor Fitzgerald
Overweight
Jan 4, 24 HC Wainwright & Co.
Buy
Oct 10, 23 Wedbush
Outperform
Aug 14, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for MannKind?
  • Does MannKind pay dividends?
  • What sector is MannKind in?
  • What industry is MannKind in?
  • What country is MannKind based in?
  • When did MannKind go public?
  • Is MannKind in the S&P 500?
  • Is MannKind in the NASDAQ 100?
  • Is MannKind in the Dow Jones?
  • When was MannKind's last earnings report?
  • When does MannKind report earnings?
  • Should I buy MannKind stock now?

What is the ticker symbol for MannKind?

The ticker symbol for MannKind is NASDAQ:MNKD

Does MannKind pay dividends?

No, MannKind does not pay dividends

What sector is MannKind in?

MannKind is in the Healthcare sector

What industry is MannKind in?

MannKind is in the Biotechnology industry

What country is MannKind based in?

MannKind is headquartered in United States

When did MannKind go public?

MannKind's initial public offering (IPO) was on July 28, 2004

Is MannKind in the S&P 500?

No, MannKind is not included in the S&P 500 index

Is MannKind in the NASDAQ 100?

No, MannKind is not included in the NASDAQ 100 index

Is MannKind in the Dow Jones?

No, MannKind is not included in the Dow Jones index

When was MannKind's last earnings report?

MannKind's most recent earnings report was on Nov 7, 2024

When does MannKind report earnings?

The next expected earnings date for MannKind is Feb 26, 2025

Should I buy MannKind stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions